Cross Country Healthcare Inc
Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse, and all… Read more
Cross Country Healthcare Inc (CCRN) - Net Assets
Latest net assets as of September 2025: $408.14 Million USD
Based on the latest financial reports, Cross Country Healthcare Inc (CCRN) has net assets worth $408.14 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($538.23 Million) and total liabilities ($130.09 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $408.14 Million |
| % of Total Assets | 75.83% |
| Annual Growth Rate | 5.17% |
| 5-Year Change | 170.45% |
| 10-Year Change | 196.41% |
| Growth Volatility | 34.92 |
Cross Country Healthcare Inc - Net Assets Trend (1999–2024)
This chart illustrates how Cross Country Healthcare Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cross Country Healthcare Inc (1999–2024)
The table below shows the annual net assets of Cross Country Healthcare Inc from 1999 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $418.96 Million | -11.50% |
| 2023-12-31 | $473.39 Million | +3.54% |
| 2022-12-31 | $457.22 Million | +53.67% |
| 2021-12-31 | $297.53 Million | +92.07% |
| 2020-12-31 | $154.91 Million | -5.25% |
| 2019-12-31 | $163.50 Million | -25.07% |
| 2018-12-31 | $218.20 Million | -8.21% |
| 2017-12-31 | $237.72 Million | +56.60% |
| 2016-12-31 | $151.80 Million | +7.40% |
| 2015-12-31 | $141.34 Million | +8.45% |
| 2014-12-31 | $130.33 Million | -26.80% |
| 2013-12-31 | $178.05 Million | -14.86% |
| 2012-12-31 | $209.12 Million | -16.12% |
| 2011-12-31 | $249.30 Million | +1.34% |
| 2010-12-31 | $246.01 Million | -0.03% |
| 2009-12-31 | $246.07 Million | +5.15% |
| 2008-12-31 | $234.02 Million | -40.06% |
| 2007-12-31 | $390.44 Million | +4.16% |
| 2006-12-31 | $374.86 Million | +4.33% |
| 2005-12-31 | $359.29 Million | +3.73% |
| 2004-12-31 | $346.37 Million | +8.07% |
| 2003-12-31 | $320.52 Million | +6.55% |
| 2002-12-31 | $300.83 Million | +11.45% |
| 2001-12-31 | $269.93 Million | +118.85% |
| 2000-12-31 | $123.34 Million | +3.87% |
| 1999-12-31 | $118.74 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cross Country Healthcare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 21805900000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $218.06 Million | 52.05% |
| Common Stock | $3.00K | 0.00% |
| Other Comprehensive Income | $-1.44 Million | -0.34% |
| Other Components | $202.34 Million | 48.30% |
| Total Equity | $418.96 Million | 100.00% |
Cross Country Healthcare Inc Competitors by Market Cap
The table below lists competitors of Cross Country Healthcare Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xinjiang Hejin Holding Co Ltd
SHE:000633
|
$276.51 Million |
|
Tecsys Inc
PINK:TCYSF
|
$276.55 Million |
|
Jiangsu Changqing Agrochemical Co Ltd
SHE:002391
|
$276.78 Million |
|
Transimex Saigon Corp
VN:TMS
|
$276.80 Million |
|
Joeone Co Ltd
SHG:601566
|
$276.49 Million |
|
Shinko Electric Industries Co. Ltd.
PINK:SHEGF
|
$276.46 Million |
|
CRYOPORT INC. DL-01
F:CKX
|
$276.41 Million |
|
Abacus Life Inc.
NASDAQ:ABL
|
$276.35 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cross Country Healthcare Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 473,393,000 to 418,959,000, a change of -54,434,000 (-11.5%).
- Net loss of 14,556,000 reduced equity.
- Share repurchases of 37,310,000 reduced equity.
- Other comprehensive income decreased equity by 56,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-14.56 Million | -3.47% |
| Share Repurchases | $37.31 Million | -8.91% |
| Other Comprehensive Income | $-56.00K | -0.01% |
| Other Changes | $-2.51 Million | -0.6% |
| Total Change | $- | -11.50% |
Book Value vs Market Value Analysis
This analysis compares Cross Country Healthcare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.72x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.77x to 0.72x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-12-31 | $5.12 | $9.06 | x |
| 2000-12-31 | $5.32 | $9.06 | x |
| 2001-12-31 | $10.70 | $9.06 | x |
| 2002-12-31 | $8.94 | $9.06 | x |
| 2003-12-31 | $9.85 | $9.06 | x |
| 2004-12-31 | $10.63 | $9.06 | x |
| 2005-12-31 | $10.96 | $9.06 | x |
| 2006-12-31 | $11.45 | $9.06 | x |
| 2007-12-31 | $12.02 | $9.06 | x |
| 2008-12-31 | $7.55 | $9.06 | x |
| 2009-12-31 | $7.94 | $9.06 | x |
| 2010-12-31 | $7.92 | $9.06 | x |
| 2011-12-31 | $7.99 | $9.06 | x |
| 2012-12-31 | $6.78 | $9.06 | x |
| 2013-12-31 | $5.74 | $9.06 | x |
| 2014-12-31 | $4.16 | $9.06 | x |
| 2015-12-31 | $4.38 | $9.06 | x |
| 2016-12-31 | $4.17 | $9.06 | x |
| 2017-12-31 | $6.56 | $9.06 | x |
| 2018-12-31 | $6.10 | $9.06 | x |
| 2019-12-31 | $4.54 | $9.06 | x |
| 2020-12-31 | $4.28 | $9.06 | x |
| 2021-12-31 | $7.96 | $9.06 | x |
| 2022-12-31 | $12.18 | $9.06 | x |
| 2023-12-31 | $13.34 | $9.06 | x |
| 2024-12-31 | $12.55 | $9.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cross Country Healthcare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.08%
- • Asset Turnover: 2.28x
- • Equity Multiplier: 1.41x
- Recent ROE (-3.47%) is below the historical average (0.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 9.72% | 5.96% | 0.63x | 2.61x | $-329.20K |
| 2000 | 3.73% | 1.25% | 1.16x | 2.58x | $-7.74 Million |
| 2001 | 3.21% | 1.73% | 1.38x | 1.34x | $-18.32 Million |
| 2002 | 9.90% | 4.65% | 1.64x | 1.30x | $-300.47K |
| 2003 | 8.06% | 3.76% | 1.45x | 1.48x | $-6.23 Million |
| 2004 | 5.96% | 3.16% | 1.43x | 1.32x | $-13.98 Million |
| 2005 | 4.11% | 2.29% | 1.34x | 1.34x | $-21.18 Million |
| 2006 | 4.44% | 2.54% | 1.30x | 1.34x | $-20.85 Million |
| 2007 | 6.30% | 3.42% | 1.34x | 1.37x | $-14.46 Million |
| 2008 | -61.08% | -19.47% | 1.72x | 1.82x | $-166.35 Million |
| 2009 | 2.72% | 1.16% | 1.62x | 1.45x | $-17.91 Million |
| 2010 | -1.13% | -0.59% | 1.35x | 1.42x | $-27.38 Million |
| 2011 | 1.64% | 0.81% | 1.50x | 1.35x | $-20.83 Million |
| 2012 | -20.19% | -9.54% | 1.45x | 1.46x | $-63.13 Million |
| 2013 | -19.42% | -7.89% | 1.76x | 1.40x | $-52.39 Million |
| 2014 | -24.47% | -5.14% | 1.90x | 2.50x | $-44.77 Million |
| 2015 | 3.14% | 0.58% | 2.10x | 2.60x | $-9.67 Million |
| 2016 | 5.27% | 0.96% | 2.15x | 2.57x | $-7.16 Million |
| 2017 | 15.82% | 4.34% | 1.85x | 1.97x | $13.80 Million |
| 2018 | -7.79% | -2.08% | 1.91x | 1.96x | $-38.70 Million |
| 2019 | -35.49% | -7.02% | 2.15x | 2.35x | $-73.98 Million |
| 2020 | -8.40% | -1.55% | 2.34x | 2.31x | $-28.40 Million |
| 2021 | 44.37% | 7.87% | 2.29x | 2.46x | $102.25 Million |
| 2022 | 40.68% | 6.63% | 2.96x | 2.07x | $140.26 Million |
| 2023 | 15.34% | 3.60% | 2.97x | 1.43x | $25.29 Million |
| 2024 | -3.47% | -1.08% | 2.28x | 1.41x | $-56.45 Million |
Industry Comparison
This section compares Cross Country Healthcare Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cross Country Healthcare Inc (CCRN) | $408.14 Million | 9.72% | 0.32x | $276.49 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |